How the brain protein TTYH1 helps move fats and ApoE in support cells and affects brain aging and Alzheimer’s

Role of TTYH1 in mobilizing lipids and ApoE in glia: Implications for brain aging and neurodegeneration

NIH-funded research Rutgers the State Univ of Nj Newark · NIH-11307173

This work looks at how a brain protein called TTYH1 helps move fats and the Alzheimer’s-linked protein ApoE in support cells, which could influence brain aging and memory loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers the State Univ of Nj Newark NIH-funded
Lab location1 site (Newark, United States)
Project IDNIH-11307173 on NIH RePORTER

What this research studies

From a patient’s perspective, researchers are focusing on a brain protein called TTYH1 and how it helps astrocytes (brain support cells) handle fats and release ApoE, a protein tied to Alzheimer’s risk. They will use human primary astrocytes, gene expression (transcriptomics), and lipid profiling (lipidomics) alongside fruit fly models to see what happens when TTYH1 is missing or altered. Laboratory cell biology experiments will examine autophagy and lipid droplet breakdown in glia and compare findings between healthy and Alzheimer’s-affected samples. The team aims to map the molecular steps linking lipid changes to cell malfunction that could point to future therapeutic targets.

Who could benefit from this research

Good fit: People with Alzheimer’s disease, related dementias, or older adults at increased risk could be relevant candidates for sample donation or future trials informed by this research.

Not a fit: Patients seeking an immediate treatment or clinical therapy would not receive direct clinical benefit from this laboratory-focused project.

Why it matters

Potential benefit: If successful, this work could reveal new molecular targets for therapies that protect brain cells and slow or prevent Alzheimer’s-related decline.

How similar studies have performed: Previous research links APOE and lipid metabolism to Alzheimer’s, but connecting TTYH1 specifically to ApoE secretion and lipid handling is a newer and less-tested area.

Where this research is happening

Newark, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.